Skip to main content

Table 3 Comparison of Metformin + Sitagliptin and Metformin + Empagliflozin pre and post Ramadan fasting

From: Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study

Groups

Variables

Before Ramadan

After Ramadan

P value

Group A (Metformin + Sitagliptin)

n  = 88

Systolic BP (mmHg)

129.55 ± 15.2

128.9 ± 16.4

0.751

Diastolic BP (mmHg)

81.1 ± 10.4

83.9 ± 14.7

0.124

Weight (Kg)

77.6 ± 13.7

77.6 ± 4.0

0.987

BMI (kg/m2)

39.5 ± 5.7

34.9 ± 4.8

0.093

RBS (mg/dl)

209 ± 99

243 ± 44

0.452

HbA1C (%)

7.8 ± 1.5

7.6 ± 1.6

0.016*

Group B (Metformin + Empagliflozin) n  = 44

Systolic BP (mmHg)

122.8 ± 17.9

123.3 ± 16.4

0.873

Diastolic BP (mmHg)

81.8 ± 8.7

85.0 ± 18.2

0.178

Weight (Kg)

85.3 ± 7.8

80.5 ± 8.4

0.716

BMI (kg/m2)

36.5 ± 4.8

33.7 ± 2.4

0.165

RBS (mg/dl)

181 ± 64

162 ± 53

0.398

HbA1C (%)

7.2 ± 0.8

6.9 ± 0.9

0.027*

  1. *P value calculated using Paired sample T test, keeping P value ≤ 0.5 as significant
  2. BMI: body mass index, RBS: random blood sugar BP: blood pressure